Get informed when a big investor buys or sells
+ FollowOvervalued by 103.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $16.22 Million |
|---|---|
| Enterprise Value | $14.80 Million |
| Earnings per Share | $-0.01 |
| Beta | -1.37 |
| Outstanding Shares | 442,052,440 |
| P/E Ratio | -4.64 |
|---|---|
| PEG | -3.05 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 211.26 |
| Enterprise Value to EBIT | -6.29 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology ...